Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS (Centers for Medicare and Medicaid Services) amends imaging agent fee schedule

This article was originally published in Clinica

Executive Summary

The Centers for Medicare & Medicaid Services (CMS) has lifted all restrictions on Medicare's payments for higher-cost imaging agents that reduce some of the potential complications associated with using a contrast agent. Low osmolar contrast materials are non-ionic agents that pose less risk of flushing, anxiety, nausea and vomiting. Although more expensive than other contrast materials, they have become standard practice among radiologists, the agency explained in announcing its rule change.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts